Outcome of the Board meeting - Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 1.8 pts less than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anirit Ventures Ltd's Board approved unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported no revenue from operations for the quarter (down from Rs 1.50 lakh in Q3 FY25) and nil for nine months FY26 (down from Rs 9.63 lakh). Net loss for Q3 FY26 widened sharply to Rs 90.53 lakh versus Rs 16.70 lakh in Q3 FY25, while the nine-month loss ballooned to Rs 263.47 lakh versus Rs 24.41 lakh last year. Employee benefit expenses surged roughly eightfold year-on-year and finance costs jumped to Rs 74.30 lakh from near-zero, driving the deepening losses. The company has negative other equity of Rs (1,319.36) lakh against paid-up capital of Rs 600 lakh, and is undertaking a rights issue of up to 1.2 crore partly paid-up shares at Rs 33 each to raise funds. The statutory auditors issued an unmodified limited review report, though without a UDIN due to a technical glitch on the ICAI portal.
Shareholders should be concerned about the company's deteriorating financial health — nil operating revenue, sharply widening losses, negative reserves, and a heavy reliance on a rights issue to sustain operations. The stock could remain under pressure until the company demonstrates revenue traction post the capital infusion.